So, you know how most stocks tend to fall when they report a bigger loss than expected? Oklo Inc. (OKLO) decided to do the opposite on Wednesday. The nuclear startup's shares were trading higher after it reported third-quarter earnings that, well, missed estimates.

Here's the thing: Oklo reported a loss of 20 cents per share for the quarter. That was wider than the 12-cent loss per share that analysts were looking for. Not exactly a beat. But the stock was up about 5%, trading around $109. Sometimes the market is less about the numbers you just printed and more about the story you're telling for the future.

And Oklo's story got a new chapter this week. The company announced on Tuesday that it signed a memorandum of understanding with the management and operating contractor for Idaho National Laboratory. The goal is to expand their collaboration on scientific and technological R&D, specifically planning to utilize Oklo's first commercial power plant, called Aurora-INL.

"This collaboration strengthens U.S. leadership in advanced nuclear and demonstrates how Oklo's model of deploying fast reactors can also accelerate learning," said Jacob DeWitte, Oklo's CEO. "We're building our first plant as a fully capable commercial product; we're also building it to learn faster, optimize faster, and keep driving down costs for future deployments."

It's a classic startup narrative: we're not just selling a product; we're building a learning platform for future scale. Investors seemed to be buying that narrative, at least for a day.

The stock's move also came as analysts made their usual post-earnings adjustments. Bank of America analyst Dimple Gosai maintained a Neutral rating but lowered the price target from $117 to $111. On the more bullish side, Wedbush analyst Dan Ives reiterated an Outperform rating and maintained a $150 price target. Perhaps most notably, B. Riley Securities analyst Ryan Pfingst maintained a Buy rating and raised his price target significantly—from $58 to $129.

Let's put the stock's move in some context. Oklo only went public this summer, so it's a relatively new name on the board. The stock's 52-week range is a wild ride from $17.14 to $193.84, reflecting a remarkable year-to-date performance of over 401%. Trading around $109 puts it roughly in the middle of that huge range.

From a technical analysis perspective, Oklo is currently trading about 9.6% below its 50-day moving average of $121.13. That might indicate a potential area of resistance if the stock tries to climb back toward that level. The 200-day moving average is way down at $65.18, so the stock is trading about 68% above that longer-term trendline, which suggests the overall trend since its debut has been strongly bullish.

The relative strength index (RSI) is sitting at 39.55, which is generally considered a neutral position—not overbought, not oversold. It's like the stock is catching its breath. In terms of support, analysts calculate a level around $97.06, which could act as a floor if the stock pulls back. There's no clearly defined resistance level from recent price action, so traders might look at round numbers like $110 or, much further out, the 52-week high near $194 as potential targets.

The big picture for Oklo is that it's still pre-revenue. The company expects to begin reporting revenue as early as next year, once ongoing projects are completed. For now, it's a story stock in the advanced nuclear sector, trading on partnerships, potential, and the long-term promise of its technology. On Wednesday, that was enough to send shares higher, even with a wider-than-expected loss.

Oklo shares were up 5.06% at $109.49 at the time of publication on Wednesday.